CX_3CR1 modulates SLE-associated glomerulonephritis and cardiovascular disease in MRL/lpr mice

[1]  Shan Sun,et al.  Phenotypic Drift in Lupus-Prone MRL/lpr Mice: Potential Roles of MicroRNAs and Gut Microbiota , 2022, ImmunoHorizons.

[2]  T. Nochi,et al.  Differential expression of CD11c defines two types of tissue-resident macrophages with different origins in steady-state salivary glands , 2021, Scientific reports.

[3]  Liwu Li,et al.  Development of Exhausted Memory Monocytes and Underlying Mechanisms , 2021, Frontiers in Immunology.

[4]  Liwu Li,et al.  Resolving monocytes generated through TRAM deletion attenuate atherosclerosis , 2021, JCI insight.

[5]  A. Tuttolomondo,et al.  Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus. , 2021, Autoimmunity reviews.

[6]  M. Griffin,et al.  Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease? , 2021, Frontiers in Immunology.

[7]  Xueyan Xi,et al.  CX3CR1 might be a promising predictor of systemic lupus erythematosus patients with pulmonary fibrosis , 2021, Scandinavian journal of immunology.

[8]  Rebecca M. Brock,et al.  Regulation of neonatal IgA production by the maternal microbiota , 2021, Proceedings of the National Academy of Sciences.

[9]  M. Weisman,et al.  A Panel of Biomarkers Associates With Increased Risk for Cardiovascular Events in Women With Systemic Lupus Erythematosus , 2021, ACR open rheumatology.

[10]  C. Reis e Sousa,et al.  Dendritic Cells Revisited. , 2021, Annual review of immunology.

[11]  P. Lipsky,et al.  Gut Microbiota and Bacterial DNA Suppress Autoimmunity by Stimulating Regulatory B Cells in a Murine Model of Lupus , 2020, Frontiers in Immunology.

[12]  A. Asakawa,et al.  Reduced brain fractalkine-CX3CR1 signaling is involved in the impaired cognition of streptozotocin-treated mice , 2020, IBRO reports.

[13]  G. Norata,et al.  Adoptive transfer of CX3CR1 transduced-T regulatory cells improves homing to the atherosclerotic plaques and dampens atherosclerosis progression. , 2020, Cardiovascular research.

[14]  Vaishali R. Moulton,et al.  Systemic lupus erythematosus favors the generation of IL-17 producing double negative T cells , 2020, Nature Communications.

[15]  P. Datta,et al.  Distinct fate, dynamics and niches of renal macrophages of bone marrow or embryonic origins , 2020, Nature Communications.

[16]  Lei Dong,et al.  CX3CL1-CX3CR1 interaction mediates macrophage-mesothelial cross talk and promotes peritoneal fibrosis. , 2019, Kidney international.

[17]  C. Reilly,et al.  Pregnancy and lactation interfere with the response of autoimmunity to modulation of gut microbiota , 2019, Microbiome.

[18]  H. Nishimura,et al.  Monocyte subsets involved in the development of systemic lupus erythematosus and rheumatoid arthritis , 2019, International immunology.

[19]  Liwu Li,et al.  Novel reprogramming of neutrophils modulates inflammation resolution during atherosclerosis , 2019, Science Advances.

[20]  Jing-Wei Zheng,et al.  Protective effects of CX3CR1 on autoimmune inflammation in a chronic EAE model for MS through modulation of antigen-presenting cell-related molecular MHC-II and its regulators , 2019, Neurological Sciences.

[21]  X. Liao,et al.  Renal‐infiltrating CD11c+ cells are pathogenic in murine lupus nephritis through promoting CD4+ T cell responses , 2017, Clinical and experimental immunology.

[22]  Xiaofeng Liao,et al.  Control of lupus nephritis by changes of gut microbiota , 2017, Microbiome.

[23]  Chen-feng Qi,et al.  The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis , 2016, Nature Communications.

[24]  J. Stumhofer,et al.  ICOS Co-Stimulation: Friend or Foe? , 2016, Front. Immunol..

[25]  V. Jha,et al.  Association of chemokine receptor CX3CR1 V249I and T280M polymorphisms with chronic kidney disease , 2016, Indian journal of nephrology.

[26]  M. Boulton,et al.  CX3CR1 deficiency accelerates the development of retinopathy in a rodent model of type 1 diabetes , 2016, Journal of Molecular Medicine.

[27]  Paul J. McMurdie,et al.  DADA2: High resolution sample inference from Illumina amplicon data , 2016, Nature Methods.

[28]  F. Powrie,et al.  CD11c+ monocyte/macrophages promote chronic Helicobacter hepaticus-induced intestinal inflammation through the production of IL-23 , 2015, Mucosal Immunology.

[29]  F. Tacke,et al.  CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: Limiting steatohepatitis by maintaining intestinal homeostasis , 2015, Hepatology.

[30]  Henrique Borges da Silva,et al.  Splenic Macrophage Subsets and Their Function during Blood-Borne Infections , 2015, Front. Immunol..

[31]  C. Kurts,et al.  The Debate about Dendritic Cells and Macrophages in the Kidney , 2015, Front. Immunol..

[32]  M. Ward,et al.  Burden of Serious Infections in Adults With Systemic Lupus Erythematosus: A National Population‐Based Study, 1996–2011 , 2015, Arthritis care & research.

[33]  S. Afrin,et al.  Fractalkine-CX3CR1-dependent recruitment and retention of human CD1c+ myeloid dendritic cells by in vitro-activated proximal tubular epithelial cells. , 2015, Kidney international.

[34]  B. Jortner,et al.  Paradoxical Effects of All-Trans-Retinoic Acid on Lupus-Like Disease in the MRL/lpr Mouse Model , 2015, PloS one.

[35]  R. Tisch,et al.  IL-2 Protects Lupus-Prone Mice from Multiple End-Organ Damage by Limiting CD4−CD8− IL-17–Producing T Cells , 2014, The Journal of Immunology.

[36]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[37]  Maria Nilsson,et al.  Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis , 2014, Proceedings of the National Academy of Sciences.

[38]  Susan Holmes,et al.  phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data , 2013, PloS one.

[39]  T. McGaha,et al.  Marginal zone macrophages suppress innate and adaptive immunity to apoptotic cells in the spleen. , 2011, Blood.

[40]  N. Glaichenhaus,et al.  CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung , 2010, Nature Medicine.

[41]  M. Nose,et al.  Fractalkine expression and CD16+ monocyte accumulation in glomerular lesions: association with their severity and diversity in lupus models. , 2010, American journal of physiology. Renal physiology.

[42]  J. Liversidge,et al.  CX3CR1‐deficiency is associated with increased severity of disease in experimental autoimmune uveitis , 2009, Immunology.

[43]  Irving L. Weissman,et al.  CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. , 2009, Blood.

[44]  M. Oukka,et al.  Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys1 , 2008, The Journal of Immunology.

[45]  G. Gilkeson,et al.  Interferon regulatory factor‐1 gene deletion decreases glomerulonephritis in MRL/lpr mice , 2006, European journal of immunology.

[46]  M. Adachi,et al.  Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations. , 2005, Arthritis and rheumatism.

[47]  S. Fujita,et al.  Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice. , 2005, Arthritis and rheumatism.

[48]  Victoria Moreno-Manzano,et al.  Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease. , 2004, Kidney international.

[49]  C. Alpers,et al.  Expression of the fractalkine receptor (CX3CR1) in human kidney diseases. , 2002, Kidney international.

[50]  E. Clark,et al.  Characterization of Human Inducible Costimulator Ligand Expression and Function1 , 2000, The Journal of Immunology.

[51]  R. Ye,et al.  NF‐κB‐dependent fractalkine induction in rat aortic endothelial cells stimulated by IL‐1β, TNF‐α, and LPS , 2000 .

[52]  Y. Xia,et al.  Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication. , 1999, Kidney international.

[53]  J. Gutiérrez-Ramos,et al.  Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation , 1997, Nature.

[54]  Wei Wang,et al.  A new class of membrane-bound chemokine with a CX3C motif , 1997, Nature.

[55]  G. Tsokos,et al.  T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. , 1989, Journal of immunology.